![Tyler Jacks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tyler Jacks
Director/Board Member at
THERMO FISHER SCIENTIFIC, INC.
Net worth: 11 M $ as of 31/05/2026
Profile
Tyler E.
Jacks is the founder of T2 Biosystems, Inc., founded in 2006, and Dragonfly Therapeutics, Inc., founded in 2016.
Current jobs include Independent Director at Amgen, Inc. since 2012, Independent Director at Thermo Fisher Scientific, Inc. since 2009, President & Director at Commonwealth Cancer Consortium, Inc. since 2021, and Professor at Massachusetts Institute of Technology since 2007.
Former jobs include Chairman at National Cancer Institute and Director at David H.
Koch Institute for Integrative Cancer Research from 2007 to 2021.
Education history includes an undergraduate degree from Harvard University in 1983 and a doctorate from The University of California, San Francisco in 1988.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/05/2026 | 18,284 ( 0% ) | 6 M $ | 31/05/2026 | |
| 20/05/2026 | 9,462 ( 0% ) | 5 M $ | 31/05/2026 |
Tyler Jacks active positions
| Companies | Position | Start |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Director/Board Member | 26/05/2009 |
| AMGEN INC. | Director/Board Member | 01/01/2012 |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | 01/01/2007 |
Commonwealth Cancer Consortium, Inc.
 Commonwealth Cancer Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit cancer research foundation | President | 01/02/2021 |
Former positions of Tyler Jacks
| Companies | Position | End |
|---|---|---|
David H. Koch Institute for Integrative Cancer Research
 David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research center | Director/Board Member | 01/01/2021 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Chairman | 01/01/2016 |
| T2 BIOSYSTEMS, INC. | Founder | 01/01/2013 |
Dragonfly Therapeutics, Inc.
 Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy to stimulate immune responses against cancer | Founder | - |
Training of Tyler Jacks
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
T2 Biosystems, Inc.
 T2 Biosystems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research center | Commercial Services |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy to stimulate immune responses against cancer | Health Technology |
Commonwealth Cancer Consortium, Inc.
Commonwealth Cancer Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit cancer research foundation | Commercial Services |
- Stock Market
- Insiders
- Tyler Jacks
